Acquisitions26 Feb 2026, 12:17 pm
Promoter Group Entity, Lenus Finvest Pvt Ltd Acquires 1.22% Stake in Eiko Lifesciences Ltd
AI Summary
On 24th February 2026, Eiko Lifesciences Ltd's Board of Directors allotted 1,75,000 equity shares and 1,50,000 warrants on a preferential basis to Lenus Finvest Private Limited, a Promoter Group Entity. This acquisition resulted in Lenus Finvest Private Limited holding 1.22% (non-diluted) and 1.09% (diluted) of the issued and subscribed equity shares of Eiko Lifesciences Limited. Post conversion of all warrants, Lenus Finvest Private Limited would hold 15.56% of the company.
Key Highlights
- Lenus Finvest Pvt Ltd, a Promoter Group Entity, acquired 1,75,000 equity shares of Eiko Lifesciences Ltd
- This acquisition represents 1.22% (non-diluted) and 1.09% (diluted) of the issued and subscribed equity shares
- Additionally, 1,50,000 warrants were allotted, which upon conversion would result in a 15.56% stake
- The transaction was completed on a preferential basis
- The acquisition was disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011